Tommaso Innocenti

15PUBLICATIONS
79CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Environmental epidemiologyImmunogenetics (incl. genetic immunology)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 11, 2026
Bridging preclinical and clinical efficacy of SIK2/SIK3 inhibition in inflammatory bowel disease through integrated murine, patient-derived models, and phase 2a trial-based analyses.

|Sep 05, 2026
Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease.

|Oct 24, 2025
The Impact of E-Cigarettes and Heat-Not-Burn Tobacco on Postoperative Recurrence of Crohn's Disease: A Multicenter International Study.

Tommaso Lorenzo Parigi, Olga Maria Nardone, Maria Lisa

|Sep 21, 2025
Systematic Review of Available Intestinal Ultrasound Scores for Inflammatory Bowel Disease and Update on Validation Studies.

Tommaso Innocenti, Carmen Rocco, Luca Scarallo

|Jul 18, 2025
Hepatic barrage to high-flow, intra-hepatic arteroportal fistulas requiring combined interventional approach.

Michele Citone, Antonluca Annese, Giacomo Gabbani

|Apr 01, 2025
Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study.

Daniele Noviello, María Chaparro, Chiara Viganò

Pageof 3

Frequent Collaborators

4 joint publications

Gabriele Dragoni

4 joint publications

Edoardo Vincenzo Savarino

3 joint publications

Sophie Vieujean

3 joint publications

Bram Verstockt